Aggiornamento aziendale23 set 2026ENProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI AdvisorProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale9 set 2026ENProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026ProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale2 set 2026ENProQR to Participate in Upcoming Investor Conferences in September 2026ProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale13 ago 2026ENProQR Announces Second Quarter 2026 Operating and Financial ResultsProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale25 giu 2026ENProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing PlatformProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale25 giu 2026ENProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private PlacementProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale12 mag 2026ENProQR Announces First Quarter 2026 Operating and Financial ResultsProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale11 mag 2026ENProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing PlatformProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale4 mag 2026ENProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026ProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale30 apr 2026ENProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of DirectorsProQR Therapeutics N.V.Company announcement feed
Aggiornamento aziendale8 apr 2026ENProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst EventProQR Therapeutics N.V.Company announcement feed
